Our findings show that spatially distinct adipose depots, specifically the abdominal SAT and mesenteric VAT, differentially affect endothelial Kir2.1 in vitro in obesity and provide new insight into the potential role of CD36 in mediating Kir2.1 and endothelial dysfunction. The gene discussed is CD36; the disease is endothelial dysfunction.